Market Place
Sourcing Support
Castle Creek Biosciences Announces Publication of Preclinical Study
30 Aug 2022 //
PRNEWSWIRE
After pulling IPO ambitions, Jeff Aronin`s Castle Creek turns to private backers
20 May 2022 //
ENDPTS
A Jeff Aronin startup quietly yanks its IPO as the biotech market ends year
30 Dec 2021 //
ENDPTS
Castle Creek Biosciences Awarded FDA Orphan Products Development Grant
21 Oct 2021 //
PRNEWSWIRE
3-peat Friday: Castle Creek, Eliem and Adagio file for IPOs
19 Jul 2021 //
FIERCEBIOTECH
Castle Creek Biosciences Announces First Patient Dosed in DeFi-RDEB Phase 3
28 Oct 2020 //
PRNEWSWIRE
Castle Creek Biosciences Announces First Patient Dosed in Pha 1/2 FCX-013
15 Oct 2020 //
PRNEWSWIRE
Castle Creek Announces First Patient in Phase 1/2 Clinical Trial of FCX-013
15 Oct 2020 //
PIPELINEREVIEW
Castle Creek Pharmaceutical Holdings Completes Acquisition of Fibrocell Science
13 Dec 2019 //
PRESS RELEASE
Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire Fibrocell
14 Sep 2019 //
BIOSPACE
Krystal Biotech eyes phase 3 for rare skin disease gene therapy
24 Jun 2019 //
FIERCE BIOTECH
Castle Creek Pharma Receives $71.8m in Funding
24 Oct 2018 //
FINSMES
Castle Creek Pharmaceuticals Receives FDA FT Designatn for Diacerein 1% Ointment
09 Aug 2018 //
PR NEWSWIRE
Castle Creek Pharmaceuticals Receives FDA Rare Pediatric Disease Designation
16 May 2018 //
PR NEWSWIRE
TWi Biotechnology Announces Collaboration with Castle Creek Pharma
16 Dec 2015 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.